Preston Klassen

Plus aucun poste en cours

Profil

Preston S.
Klassen worked at Amgen, Inc. as Executive Director-Medical from 2002 to 2009.
From 2009 to 2016, worked at Orexigen Therapeutics, Inc. as Executive VP & Head-Global Development.
Served as Independent Director at Conatus Pharmaceuticals, Inc. from 2014 to 2020.
Held the position of Chief Medical Officer, Executive VP, Head-R&D at Arena Pharmaceuticals, Inc. from 2017 to 2020.
Was President & Chief Medical Officer at Sanifit Therapeutics SA from 2016 to 2017.
Served as President, Chief Executive Officer & Director at Metacrine, Inc. from 2020 to 2023.
Held the role of President & Chief Operating Officer at Zura Bio Ltd. in 2023.
Worked as President, Director & Head-Research & Development at Regulus Therapeutics, Inc. from 2023 to 2025.
Held director positions at Corvidia Therapeutics, Inc., Equillium, Inc., and Chinook Therapeutics, Inc. Also served as President & Chief Marketing Officer at Sanifit, Inc. Education includes undergraduate degree from Central College, doctorate from the University of Nebraska Medical Center, and graduate degree from Duke University in 2000.

Anciens postes connus de Preston Klassen

Sociétés	Poste	Fin
REGULUS THERAPEUTICS INC.	President	25/06/2025
ZURA BIO LIMITED	President	11/04/2023
METACRINE, INC.	Directeur Général	01/02/2023
ARENA PHARMACEUTICALS	Directeur Technique/Scientifique/R&D	09/06/2020
HISTOGEN INC.	Directeur/Membre du Conseil	01/05/2020